Elevation Acquisition Group Inc. (ELEV)
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Sector: Blank Checks
Industry: Biotechnology
Elevation Oncology, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
USElevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles.
Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion.
The company was established in 2019 and is headquartered in New York, New York.
Leadership
Joseph J. Ferra Jr.
Chief Executive Officer, President & Director
Valerie Malyvanh Jansen
Chief Medical Officer
Biren Shah
Senior Vice President of Business & Corporate Development
Robert C. Yang
Senior Vice President & General Counsel
Employees
--
Country
US
Sector
Healthcare
Website
elevationoncology.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Sandler Alan B. | Director | Withholding/Transfer | 35.0K | -- | Jul 23, 2025 |
| Sandler Alan B. | Director | Withholding/Transfer | 35.0K | -- | Jul 23, 2025 |
| Sandler Alan B. | Director | Withholding/Transfer | 55.0K | -- | Jul 23, 2025 |
 Furlong Tammy | CHIEF FINANCIAL OFFICER | Withholding/Transfer | 225.0K | -- | Jul 23, 2025 |
| Furlong Tammy | CHIEF FINANCIAL OFFICER | Withholding/Transfer | 53.4K | -- | Jul 23, 2025 |
| Furlong Tammy | CHIEF FINANCIAL OFFICER | Withholding/Transfer | 28.8K | -- | Jul 23, 2025 |
Insiders
- Sandler Alan B.Director
- Furlong TammyCHIEF FINANCIAL OFFICER
- CLACKSON TIMOTHY PDirector
- Carruthers R MichaelDirector
- Cherrington Julie MDirector
- ELMS STEVEDirector
- Mootz DarcyDirector
- Ferra Joseph J JrCHIEF EXECUTIVE OFFICER
- Dornan DavidCHIEF SCIENTIFIC OFFICER
- Jansen Valerie MalyvanhCHIEF MEDICAL OFFICER
US30d Avg
--
60d Avg
--
90d Avg
--